These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35130574)

  • 1. Management of Multidrug-Resistant Infections in Cirrhosis.
    Gallaher CE; Shawcross DL
    Semin Liver Dis; 2022 May; 42(2):173-187. PubMed ID: 35130574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms.
    Addo Smith JN; Yau R; Russo HP; Putney K; Restrepo A; Garey KW; Sofjan AK
    J Clin Gastroenterol; 2018 Aug; 52(7):648-654. PubMed ID: 29176351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis.
    Mücke MM; Mayer A; Kessel J; Mücke VT; Bon D; Schwarzkopf K; Rüschenbaum S; Queck A; Göttig S; Vermehren A; Weiler N; Welker MW; Reinheimer C; Hogardt M; Vermehren J; Herrmann E; Kempf VAJ; Zeuzem S; Lange CM
    Clin Infect Dis; 2020 Apr; 70(9):1916-1924. PubMed ID: 31228250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis.
    Prado V; Hernández-Tejero M; Mücke MM; Marco F; Gu W; Amoros A; Toapanta D; Reverter E; Peña-Ramirez C; Altenpeter L; Bassegoda O; Mezzano G; Aziz F; Juanola A; Rodríguez-Tajes S; Chamorro V; López D; Reyes M; Hogardt M; Kempf VAJ; Ferstl PG; Zeuzem S; Martínez JA; Vila J; Arroyo V; Trebicka J; Fernandez J
    J Hepatol; 2022 May; 76(5):1079-1089. PubMed ID: 35074475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Exposure to High-risk Antibiotics in Acute Care Hospitals With Multidrug-Resistant Organism Burden in Nursing Homes.
    Gontjes KJ; Gibson KE; Lansing BJ; Mantey J; Jones KM; Cassone M; Wang J; Mills JP; Mody L; Patel PK
    JAMA Netw Open; 2022 Feb; 5(2):e2144959. PubMed ID: 35103795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.
    Marciano S; Gutierrez-Acevedo MN; Barbero S; Del C Notari L; Agozino M; Fernandez JL; Anders MM; Grigera N; Antinucci F; Orozco Ganem OF; Murga MD; Perez D; Palazzo A; Martinez Rejtman L; Duarte IG; Vorobioff J; Trevizan V; Bulaty S; Bessone F; Valverde M; Elizondo M; Bosia JD; Borzi SM; Stieben TE; Masola A; Ferretti SE; Arufe D; Demirdjian E; Raffa MP; Peralta M; Fainboim HA; Vazquez CE; Ruiz P; Martínez JE; Heffner LA; Odzak A; Dirchwolf M; Smud A; Mendizabal M; Bellizzi C; Martinez A; Tomatis J; Bruno A; Ramos A; Pages J; Tevez S; Gadano AC; Giunta DH
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):481-491. PubMed ID: 36820931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
    Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
    J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study.
    Dalbeni A; Mantovani A; Zoncapè M; Cattazzo F; Bevilacqua M; De Marco L; Paon V; Ieluzzi D; Azzini AM; Carrara E; Tacconelli E; Sacerdoti D
    PLoS One; 2023; 18(2):e0281813. PubMed ID: 36795664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for the emergence of multidrug-resistant organisms in liver cirrhosis.
    Figueiredo LM; Rafael MA; Alexandrino G; Branco JC; Carvalho R; Costa MN; Martins A
    Gastroenterol Hepatol; 2022 Mar; 45(3):186-191. PubMed ID: 34052400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding.
    Mücke VT; Peiffer KH; Kessel J; Schwarzkopf KM; Bojunga J; Zeuzem S; Finkelmeier F; Mücke MM
    PLoS One; 2022; 17(5):e0268638. PubMed ID: 35609050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications.
    Li H; Wieser A; Zhang J; Liss I; Markwardt D; Hornung R; Neumann-Cip AC; Mayerle J; Gerbes A; Steib CJ
    Eur J Clin Invest; 2020 Feb; 50(2):e13198. PubMed ID: 31886517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Reducing Antibiotics on the Transmission of Multidrug-Resistant Organisms.
    Barnes SL; Rock C; Harris AD; Cosgrove SE; Morgan DJ; Thom KA
    Infect Control Hosp Epidemiol; 2017 Jun; 38(6):663-669. PubMed ID: 28270258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms.
    Wang J; Foxman B; Mody L; Snitkin ES
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10467-10472. PubMed ID: 28900004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.
    Magira EE; Islam S; Niederman MS
    Med Intensiva (Engl Ed); 2018 May; 42(4):225-234. PubMed ID: 29033075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of bacterial and fungal infections in cirrhosis: The MDRO challenge.
    Fernández J; Piano S; Bartoletti M; Wey EQ
    J Hepatol; 2021 Jul; 75 Suppl 1():S101-S117. PubMed ID: 34039482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia.
    Mitchell SL; Shaffer ML; Loeb MB; Givens JL; Habtemariam D; Kiely DK; D'Agata E
    JAMA Intern Med; 2014 Oct; 174(10):1660-7. PubMed ID: 25133863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
    Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M
    PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
    Allaire M; Cadranel JF; Nguyen TTN; Garioud A; Zougmore H; Heng R; Perignon C; Ollivier-Hourmand I; Dao T
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):264-274. PubMed ID: 31706985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antibiotic strategies in patients with cirrhosis and bacterial infection.
    Fernández J; Acevedo J
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1495-500. PubMed ID: 26465070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis.
    Mattos AA; Wiltgen D; Jotz RF; Dornelles CMR; Fernandes MV; Mattos ÂZ
    Ann Hepatol; 2020; 19(5):451-457. PubMed ID: 32533951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.